Ruiz-Ibán Miguel Angel, Gonzalez-Lizán Fausto, Diaz-Heredia Jorge, Elías-Martin Maria Elena, Correa Gorospe Carlos
Department of Orthopaedic Surgery and Trauma, Hospital Universitario Ramón y Cajal, Cta Colmenar Km 9.100, 28034, Madrid, Spain.
Department of Anesthesiology and Reanimation, Hospital Universitario Ramón y Cajal, Cta Colmenar Km 9.100, 28034, Madrid, Spain.
Knee Surg Sports Traumatol Arthrosc. 2015 May;23(5):1393-1400. doi: 10.1007/s00167-013-2785-4. Epub 2013 Dec 3.
Long-bone segmental defects caused by infection, fracture, or tumour are a challenge for orthopaedic surgeons. Structural allografts are sometimes used in their treatment but their poor biological characteristics are a liability. The objective of this study was to determine whether the addition of recombinant vascular endothelial growth factor-A (VEGF) to a structural allograft improved its integration into a rabbit tibial segmental defect in a non-union model.
Tibial segmental defects were filled with heat sterilized allogenic tubular tibiae sections and then stabilized with a screw plate. In the VEGF treatment group (n = 6 tibiae), 2 μg of VEGF added to a 50 μl matrigel solution was inserted into the allograft cavity. In the control group (n = 6 tibiae), only matrigel was added. After 12 weeks, macroscopic and microscopic analysis, radiographs, and computerized micro-tomography (micro-CT) were performed. If allograft consolidation was present, a torsional resistance analysis was performed.
Addition of VEGF to the allograft decreased the rate of osteosynthesis failure compared with the control group (1/6 vs. 5/6, p = 0.08), increased trabecular continuity evaluated by micro-CT in the bone-allograft interphases (8/12 vs. 2/12, p = 0.036) and histological trabecular continuity (7/12 vs. 0/12, p = 0.0046). Full consolidation was observed in three tibiae of the VEGF group and one in the control group (differences not significant); however, torsional resistance showed no significant differences (n.s.).
Addition of VEGF to a structural allograph inserted into a rabbit tibial segmental defect increased allograft integration rate. Further research in this direction might help clinicians in dealing with large bone defects.
由感染、骨折或肿瘤导致的长骨节段性缺损对骨科医生而言是一项挑战。结构异体骨有时用于其治疗,但它们较差的生物学特性是一个缺陷。本研究的目的是确定在结构异体骨中添加重组血管内皮生长因子-A(VEGF)是否能改善其在兔胫骨节段性缺损不愈合模型中的整合情况。
用热灭菌的同种异体管状胫骨段填充胫骨节段性缺损,然后用螺钉钢板固定。在VEGF治疗组(n = 6条胫骨)中,将添加到50 μl基质胶溶液中的2 μg VEGF注入异体骨腔。在对照组(n = 6条胫骨)中,仅添加基质胶。12周后,进行宏观和微观分析、X线片以及计算机微断层扫描(显微CT)。如果存在异体骨融合,则进行抗扭转分析。
与对照组相比,在异体骨中添加VEGF降低了骨合成失败率(1/6 vs. 5/6,p = 0.08),通过显微CT评估增加了骨-异体骨界面处的小梁连续性(8/12 vs. 2/12,p = 0.036)以及组织学小梁连续性(7/12 vs. 0/12,p = 0.0046)。在VEGF组的三条胫骨中观察到完全融合,对照组中有一条(差异不显著);然而,抗扭转性没有显著差异(无统计学意义)。
在插入兔胫骨节段性缺损的结构异体骨中添加VEGF可提高异体骨整合率。在这个方向上的进一步研究可能有助于临床医生处理大的骨缺损。